Description

• NOVOMAX FUSION is developed as implants for the stabilization of the anterior cervical spondylodesis. NOVOMAX FUSION is made of CaO-SiO₂-P₂O₅-B₂O₃ based crystallized-glass (BGS-7) which has high mechanical strength, makes direct bone fusion and is biocompatible.
• NOVOMAX FUSION is provided sterile for single use.

Indications for Use

NOVOMAX FUSION is indicated for use in patients with degenerative disc disease (DDD) of the cervical spine accompanying radicular symptoms from C3 to T1.

NOVOMAX FUSION is to be implanted via an anterior approach.

NOVOMAX FUSION is intended to be used with supplemental fixation systems that have been cleared for use in the cervical spine (i.e., screw and plate systems).

Intended Purpose

• NOVOMAX FUSION is intended for patients spinal instability, degenerative disc disease, spinal fracture, or other conditions requiring stabilization and alignment of the vertebral column. It addresses various clinical forms, stages, and severities of these conditions, aiming to alleviate pain, correct deformities, and promote spinal fusion.
• NOVOMAX FUSION is intended for adult patients.
• NOVOMAX FUSION is intended for single use implantation.
• NOVOMAX FUSION should be used by qualified healthcare professionals in appropriate surgical settings. It should be used in accordance with established medical practices and guidelines. Regular follow-up and imaging may be necessary to monitor the fusion progress and overall spinal health of the patient.